About our company
Madam Therapeutics is an innovative biotech company from the Netherlands that aims to develop novel antimicrobial therapies.
Our main focus is to reduce the societal and economic burden associated with antimicrobial resistance and to prevent the scenario wherein untreatable infections are predicted to cause 10 million annual deaths by the year 2050.
Due to Madam Therapeutics’ strong IP position and SAAPs superior characteristics compared to existing solutions and competitors, the company aims to become a leading innovator in the AMR field.
Going for excellence
After successfully bringing Madam Therapeutics’ first showcase to the market, the company will expand the portfolio for systemic indications including respiratory infections in cystic fibrosis, implant coatings, Lyme disease or sepsis.